FDA Drug Application (090631) for CARBIDOPA AND LEVODOPA by IMPAX LABS

Back to FDA Applications sponsored by IMPAX LABS

Application Number090631
Product Number001
FormTABLET, ORALLY DISINTEGRATING;ORAL
Dosage10MG;100MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameCARBIDOPA AND LEVODOPA
Active IngredientCARBIDOPA; LEVODOPA



Back to FDA Applications sponsored by IMPAX LABS

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.